Lisata Therapeutics (LTS:0HS8) Cyclically Adjusted Book per Share: $32.97 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0HS8 Lisata Therapeutics Inc LTS:0HS8
23 GF Score
Price $1.45
! 3 Warning Signs
View Full Analysis

What is Lisata Therapeutics Cyclically Adjusted Book per Share?

Lisata Therapeutics LTS:0HS8 +31.82% 23 Cyclically Adjusted Book per Share is $32.97 as of Jun. 2026. GuruFocus rates LTS:0HS8 with a GF Score™ of 23/100. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Lisata Therapeutics's adjusted book value per share for the three months ended in Jun. 2026 was $0.904. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $32.97 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Lisata Therapeutics's average Cyclically Adjusted Book Growth Rate was -18.60% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -34.20% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -33.90% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was -24.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Lisata Therapeutics was 20.10% per year. The lowest was -34.20% per year. And the median was -5.80% per year.

As of today (2026-08-24), Lisata Therapeutics's current stock price is $1.45. Lisata Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was $32.97. Lisata Therapeutics's Cyclically Adjusted PB Ratio of today is 0.04.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Lisata Therapeutics was 0.19. The lowest was 0.01. And the median was 0.06.


Lisata Therapeutics  (LTS:0HS8) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Lisata Therapeutics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1.45/32.97
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Lisata Therapeutics was 0.19. The lowest was 0.01. And the median was 0.06.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Lisata Therapeutics Cyclically Adjusted Book per Share Related Terms


Lisata Therapeutics Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Lisata Therapeutics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lisata Therapeutics Cyclically Adjusted Book per Share Chart

Lisata Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 175.33 114.78 91.48 50.91 35.30

Lisata Therapeutics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.35 35.10 35.30 33.56 32.97

LTS:0HS8 vs CYCN, OSRH, ICU: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Lisata Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lisata Therapeutics Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lisata Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Lisata Therapeutics's Cyclically Adjusted PB Ratio falls into.


LTS:0HS8
23GF Score
Lisata Therapeutics Inc LTS:0HS8
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lisata Therapeutics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Lisata Therapeutics's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.904/333.9520*333.9520
=0.904

Current CPI (Jun. 2026) = 333.9520.

Lisata Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201609 19.717 241.428 27.273
201612 8.945 241.432 12.373
201703 -1.325 243.801 -1.815
201706 91.618 244.955 124.905
201709 84.925 246.819 114.906
201712 79.916 246.524 108.258
201803 71.455 249.554 95.621
201806 67.500 251.989 89.455
201809 62.625 252.439 82.847
201812 57.334 251.233 76.211
201903 50.113 254.202 65.835
201906 43.130 256.143 56.232
201909 36.380 256.759 47.317
201912 29.652 256.974 38.534
202003 24.320 258.115 31.465
202006 32.542 257.797 42.155
202009 29.188 260.280 37.450
202012 25.152 260.474 32.247
202103 27.796 264.877 35.045
202106 26.445 271.696 32.505
202109 24.760 274.310 30.143
202112 23.145 278.802 27.723
202203 21.926 287.504 25.468
202206 20.399 296.311 22.990
202209 9.160 296.808 10.306
202212 8.428 296.797 9.483
202303 7.622 301.836 8.433
202306 7.128 305.109 7.802
202309 6.507 307.789 7.060
202312 5.908 306.746 6.432
202403 5.176 312.332 5.534
202406 4.597 314.175 4.886
202409 4.049 315.301 4.289
202412 3.517 315.605 3.721
202503 2.942 319.799 3.072
202506 2.438 322.561 2.524
202509 1.984 324.800 2.040
202512 1.682 324.054 1.733
202603 1.200 330.213 1.214
202606 0.904 333.952 0.904

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $32.97 mean?
Lisata Therapeutics (LTS:0HS8) has a Cyclically Adjusted Book per Share of $32.97 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Lisata Therapeutics and its competitors.
Is Lisata Therapeutics' Cyclically Adjusted Book per Share too high?
Lisata Therapeutics' current Cyclically Adjusted Book per Share is $32.97. Overall, Lisata Therapeutics has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Lisata Therapeutics' Cyclically Adjusted Book per Share compare to CYCN and OSRH?
Lisata Therapeutics' Cyclically Adjusted Book per Share of $32.97 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Lisata Therapeutics and its competitors. Lisata Therapeutics's current Cyclically Adjusted Book per Share is $32.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lisata Therapeutics stock overvalued right now?
Lisata Therapeutics (LTS:0HS8) has a current Cyclically Adjusted Book per Share of $32.97. The current Cyclically Adjusted Book per Share is $32.97. Lisata Therapeutics' overall GF Score™ is 23/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Lisata Therapeutics (LTS:0HS8), the current Cyclically Adjusted Book per Share is $32.97 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lisata Therapeutics Business Description

Other Exchanges LSTA:USA8NE:Germany
Address 110 Allen Road, 2nd Floor, Basking Ridge, NJ, USA, 07920
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.
23GF Score

Get the complete analysis for LTS:0HS8

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.45
Price